English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Avascular necrosis (AVN) could remain with negligible clinical symptoms, but it would get worsen over the time if it’s left untreated and at the most cases will require surgical treatment. Prevalence of femoral head AVN is almost 0.45% among HIV patients which is approximately 45 times more than the rest of Society. AVN occurs 0.088%-1.33% annually among HIV victims. Avascular necrosis of the femoral head is a bone deteriorating plight. At this study, the clinical prevalence of it has been analyzed among a group of 180 patients at Rasool-e-Akram Hospital (Iran, between 2008 and 2016). Patients were including 121 men and 59 women. Analysis results showed that the prevalence of HCV, HBV, and HIV was 1.7%, 1.1%, and 1.1% respectively. It was found that 63% Review Article Yeghaneh et al.; JPRI, 30(4): 1-7, 2019; Article no.JPRI.52171 2 of patients was currently using immunosuppressive drugs. 17% had a history of drug abuse among which 3.3% were using IV drugs. It was concluded that femoral head AVN is more common among hepatitis and HIV patients.

journal of pharmaceutical research international

Prevalence Study of Femoral Head Avascular Necrosis and Evaluating Mutual Connection between Injury and Viral Infections: Clinical Analysis and Brief Review